EXPANDING NILOTINIB ACCESS IN CLINICAL TRIALS (ENACT) STUDY IN ADULT PATIENTS WITH IMATINIB-RESISTANT OR INTOLERANT CHRONIC MYELOID LEUKEMIA (CML): UPDATED SAFETY ANALYSIS

被引：0
|
作者：
Nicolini, F. [1 ]
Alimena, G. [2 ]
Shen, Z. [3 ]
Al-Ali, H. -K [4 ]
Turkina, A. [5 ]
Smith, G. [6 ]
Pasquini, R. [7 ]
Jootar, S. [8 ]
Hsu, Y. [9 ]
Veronese, M. L. [9 ]
Powell, B. [10 ]
机构：
[1] Hop Edouard Herriot, Lyon, France
[2] Univ Roma La Sapienza, Rome, Italy
[3] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Shanghai 200030, Peoples R China
[4] Univ Leipzig, Med Klin & Poliklin 2, Leipzig, Germany
[5] Hematol Sci Ctr, Moscow, Russia
[6] Leeds Teaching Hosp, Leeds, W Yorkshire, England
[7] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil
[8] Mahidol Univ, Salaya, Thailand
[9] Nova Pharmaceut Corp, E Hanover, NJ USA
[10] Wake Forest Univ, Baptist Med Ctr, Ctr Comprehens Canc, Winston Salem, NC 27109 USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O134
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [31] Nilotinib in patients with imatinib-resistant or -intolerant chronic myelogenous leukaemia in chronic phase (CML-CP): updated phase 2 results
    Clark, R.
    Kantarjian, H. M.
    Giles, F. J.
    Hochhaus, A.
    Bhalla, K. N.
    Ossenkoppele, G.
    Gattermann, N.
    Haque, A.
    Gallagher, N.
    Baccarani, M.
    le Coutre, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 57 - 58
  • [32] BCR-ABL transcript analysis of patients (pts) with imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase (CML-CP) treated with nilotinib.
    Kim, D.
    Saglio, G.
    Martinelli, G.
    Shou, Y.
    Stein, A. M.
    Woodman, R. C.
    Kantarjian, H.
    Hughes, T. P.
    Radich, J. P.
    Hochhaus, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
    J Cortes
    D-W Kim
    E Raffoux
    G Martinelli
    E Ritchie
    L Roy
    S Coutre
    S Corm
    N Hamerschlak
    J-L Tang
    A Hochhaus
    H J Khoury
    T H Brümmendorf
    M Michallet
    G Rege-Cambrin
    C Gambacorti-Passerini
    J P Radich
    T Ernst
    C Zhu
    J M A Van Tornout
    M Talpaz
    Leukemia, 2008, 22 : 2176 - 2183
  • [34] RESPONSE TO NILOTINIB IN PATIENTS WITH IMATINIB-RESISTANT OR -INTOLERANT CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WITH DIFFERENT BCR-ABL TRANSCRIPT TYPES
    Saglio, S.
    Hughes, T.
    Kim, D. W.
    Hanfstein, B.
    Gottardi, E.
    Branford, S.
    Goh, H.
    Beppu, L.
    Soverini, S.
    Shou, Y.
    Stein, A.
    Woodman, R.
    Kantarjian, H.
    Radich, J.
    Hochhaus, A.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 342 - 343
  • [35] DASATINIB TREATMENT OF IMATINIB-RESISTANT AND IMATINIB-INTOLERANT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN A CHRONIC PHASE
    Vinogradova, O. Yu.
    Turkina, A. G.
    Vorontsova, A. V.
    Chelysheva, E. Yu.
    Gusarova, G. A.
    Kuznetsov, S. V.
    Goryacheva, S. R.
    Sokolova, M. A.
    Abakumov, E. M.
    Stakhina, O. V.
    Domracheva, E. V.
    Misyurin, A. V.
    Khoroshko, N. D.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (07) : 41 - 46
  • [36] Compassionate use of nilotinib (AMN107) in Mexican patients with chronic myeloid leukemia (CML) resistant or intolerant to imatinib
    Ayala, Manuel
    Hurtado, Rafael
    Nacho, Kevin
    Tapia, Norma
    Alvarado, Martha
    Aguayo, Alvaro
    Cleto, Sergio
    Lugo, Yolanda
    Reyes, Gustavo
    Vargas, Pablo
    Herrera, Angel
    Meillon, Luis Antonio
    BLOOD, 2007, 110 (11) : 216B - 216B
  • [37] NILOTINIB IN IMATINIB RESISTANT OR INTOLERANT PATIENTS WITH CHRONIC MYELOID LEUKEMIA - SINGLE CENTRE EXPERIENCE
    Sninska, Z.
    Martisova, M.
    Slezakova, K.
    Hatalova, A.
    Demeckova, E.
    Mistrik, M.
    HAEMATOLOGICA, 2012, 97 : 541 - 542
  • [38] BUDGET IMPACT ANALYSIS OF DASATINIB IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) IN BRAZIL
    Asano, E.
    Nita, M.
    Moellmann-Coelho, A.
    Rached, R.
    Donato, B.
    Rahal, E.
    VALUE IN HEALTH, 2009, 12 (07) : A262 - A262
  • [39] QUALITY OF LIFE AND SYMPTOM PROFILE IN PATIENTS WITH IMATINIB-RESISTANT OR -INTOLERANT CHRONIC MYELOID LEUKEMIA
    Ionova, I.
    Nikitina, T.
    Gritsenko, T.
    Ivanova, V.
    Kuchma, G.
    Fedorenko, D.
    Kurbatova, K.
    HAEMATOLOGICA, 2012, 97 : 314 - 314
  • [40] ANALYSIS OF BCR-ABL MUTATIONS IN MEXICAN PATIENTS WITH IMATINIB-RESISTANT OR -INTOLERANT PHILADELPHIA-CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA (PH plus CML) TREATED WITH NILOTINIB
    Ayala, J. L.
    Hurtado, R.
    Delgado, N.
    Vargas, P.
    Meillon, L.
    Tapia, N.
    Alvarado, M.
    De Diego, J.
    Azaola, P.
    Gonzalez, M.
    Lugo, Y.
    Hernandez, R.
    Kassack, J. J.
    Cleto, S.
    Nambo, M.
    Reyes, G.
    Cantu, O.
    Aguayo, A.
    Mucius, I.
    Herrera, A.
    Nacho, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 220 - 220
12345